Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.
Observe Medical is listed on Euronext Oslo under OBSRV.
Observe Medical ASA has today, May 26, 2023, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. For further information, please contact: Rune Nystad, CEO Observe Medical Mobile:…
Read moreOslo, 26 May 2023 – Observe Medical ASA (the "Company" or "Observe Medical") has received initial orders from distributors for delivery of UnoMeter™ products and is expecting to ship the first units to customers in June. The total value of these initial orders is NOK 8.2 million. The distributors that have signed the orders have…
Read moreOslo, May 5, 2023 – Observe Medical ASA (OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, May 26, 2023, at 10:00 (CET). The annual general meeting will be held at Dronning Eufemias gate 16, 0191 Oslo for those attending in person. The Notice of the Annual General Meeting is attached.…
Read moreAs at 24 May 2023.
| Name | Number of shares | % of top 20 | % of total | Country | ||
|---|---|---|---|---|---|---|
| 1 | INGERØ REITEN INVESTMENT COMPANY AS | 9,653,680 | 29.09% | 18.05% | Norway | |
| 2 | NAVAMEDIC ASA | 4,222,727 | 12.72% | 7.89% | Norway | |
| 3 | RO, LARS | 3,414,949 | 10.29% | 6.38% | Norway | |
| 4 | JPB AS | 2,830,209 | 8.53% | 5.29% | Norway | |
| 5 | ELI AS | 1,744,260 | 5.26% | 3.26% | Norway | |
| 6 | MP PENSJON PK | 1,676,188 | 5.05% | 3.13% | Norway | |
| 7 | UBS Switzerland AG | 1,482,913 | 4.47% | 2.77% | Switzerland | |
| 8 | SKÅLVOLD EIENDOM AS | 924,500 | 2.79% | 1.73% | Norway | |
| 9 | NORDNET LIVSFORSIKRING AS | 827,051 | 2.49% | 1.55% | Norway | |
| 10 | BJØRNTVEDT, VEGARD | 809,962 | 2.44% | 1.51% | Norway | |
| 11 | LAPAS AS | 805,185 | 2.43% | 1.51% | Norway | |
| 12 | Nordnet Bank AB | 646,113 | 1.95% | 1.21% | Sweden | |
| 13 | SILVERCOIN INDUSTRIES AS | 602,872 | 1.82% | 1.13% | Norway | |
| 14 | SOLEGLAD INVEST AS | 586,668 | 1.77% | 1.10% | Norway | |
| 15 | TAJ HOLDING AS | 500,847 | 1.51% | 0.94% | Norway | |
| 16 | GINNY INVEST AS | 500,000 | 1.51% | 0.93% | Norway | |
| 17 | ELMON AS | 500,000 | 1.51% | 0.93% | Norway | |
| 18 | TRANBERGKOLLEN INVEST AS | 500,000 | 1.51% | 0.93% | Norway | |
| 19 | CAM AS | 481,000 | 1.45% | 0.90% | Norway | |
| 20 | BRØDRENE KARLSEN HOLDING AS | 479,868 | 1.45% | 0.90% | Norway | |
| Total number owned by top 20 | 33,188,992 | 100.00% | 62.05% | |||
| Total number of shares | 53,491,656 | |||||
| Total number of shareholders | 1,990 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Euronext Expand Oslo
OBSRV
4 November 2019
Healthcare
NOK
NO0010865009
53 491 656
NOK 0.26
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no
26 May 2023: Observe Medical ASA - Minutes from Annual General Meeting
26 May 2023: Represented List
5 May 2023:Notice of Annual General Meeting on 26 May 2023
5 May 2023: Notice of attendance and proxy form to the AGM on 26 May 2023
5 May 2023: VPS - Investor services
5 May 2023: Nomination Committee recommendation
5 May 2023: Observe Medical - Report of salary and other remuneration to leading personnel
3 June 2022: Minutes from Annual General Meeting 2022
3 June 2022: Represented list
31 May 2022: Board of Directors recommendation for appointment of auditor
31 May 2022: The Nomination Committee recommendation part 2
13 May 2022: Notice of Annual General Meeting on 3 June 2022
13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022
13 May 2022: The Nomination Committee’s recommendation (part 1)
13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel
13 May 2022: Report on salary and other remuneration to executive personnel year 2021
13 May 2022: VPS – Investor services
13 May 2022: LUMI
13 May 2022: Online guide LUMI (Norsk)
13 May 2022: Online guide LUMI (English)
4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022
21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021
30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021
30 April 2021: The Nomination Committee's recommendation
30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
Rune Nystad, Chief Executive Officer +47 91 62 46 83 / rune.nystad@observemedical.com
Per Arne Nygård, Chief Financial Officer +47 41 10 43 45 / perarne.nygard@observemedical.com